Immune cell boost after transplant shows promise against tough blood cancers
NCT ID NCT05115630
First seen Jan 05, 2026 · Last updated May 17, 2026 · Updated 14 times
Summary
This study tested whether adding ready-made natural killer (NK) cells from a donor to a standard stem cell transplant could safely reduce the chance of cancer coming back in people with high-risk myeloid cancers like acute myeloid leukemia. Twenty-four patients aged 18 to 70 took part. The approach aims to strengthen the immune system's attack on any remaining cancer cells after the transplant.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Caner Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.